Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Ketorolac, Lidocaine, or Dexamethasone in Trigger Point Injections
NCT03028012Phase 4Terminated
- Sponsor
- University of Utah
- Start
- May 2017
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac, dexamethasone in myofascial pain syndrome (MPS), sponsored by University of Utah. Started May 2017; status: terminated.
02
Drugs
ketorolacdexamethasone
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT03028012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028012.